title: Oral vitamin C enhances the adrenergic vasoconstrictor response to local cooling in human skin.
abstract: Local administration of ascorbic acid (Asc) at a supraphysiological concentration inhibits the cutaneous vasoconstrictor response to local cooling (LC). However, whether orally ingesting Asc inhibits the LC-induced vasoconstrictor response remains unknown. The purpose of the present study was to examine the acute influence of oral Asc on the adrenergic vasoconstrictor response to LC in human skin. In experiment 1, skin blood flow (SkBF) was measured by laser-Doppler flowmetry at three sites (forearm, calf, palm). The three skin sites were locally cooled from 34 to 24°C at -1°C/min and maintained at 24°C for 20 min before (Pre) and 1.5 h after (Post) oral Asc (2-g single dose) or placebo supplementation. Cutaneous vascular conductance (CVC) was calculated as the ratio of SkBF to blood pressure and expressed relative to the baseline value before LC. Oral Asc enhanced (P < 0.05) the reductions in CVC in the forearm (Pre, -50.3 ± 3.3%; Post, -57.8 ± 2.2%), calf (Pre, -52.6 ± 3.7%; Post, -66.1 ± 4.3%), and palm (Pre, -46.2 ± 6.2%; Post, -60.4 ± 5.6%) during LC. The placebo did not change the responses at any site. In experiment 2, to examine whether the increased vasoconstrictor response caused by oral Asc is due to the adrenergic system, the release of neurotransmitters from adrenergic nerves in forearm skin was blocked locally by iontophoresis of bretylium tosylate (BT). Oral Asc enhanced (P < 0.05) the reductions in CVC at untreated control sites but did not change the responses at BT-treated sites during LC. In experiment 3, to further examine whether adrenergically mediated vasoconstriction is enhanced by oral Asc, 0.1 mM tyramine was administered using intradermal microdialysis in the forearm skin at 34°C in the Pre and Post periods. Oral Asc increased (P < 0.05) the tyramine-induced reduction in CVC. These findings suggest that oral Asc acutely enhances the cutaneous vasoconstrictor responses to LC through the modification of adrenergic sympathetic mechanisms.
authors.affiliation: Laboratory for Human Physiology, School of Health Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan. yamazaki@health.uoeh-u.ac.jp
authors.forename: Fumio
authors.initials: F
authors.lastname: Yamazaki
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000320:Adrenergic Fibers / Q000187:drug effects* / Q000378:metabolism; D000704:Analysis of Variance; D001205:Ascorbic Acid / Q000008:administration & dosage*; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000294:innervation*; D001950:Bretylium Tosylate / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007036:Hypothermia, Induced; D007478:Iontophoresis; D007564:Japan; D017078:Laser-Doppler Flowmetry; D008297:Male; D017551:Microdialysis; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply*; D012881:Skin Temperature; D013997:Time Factors; D014439:Tyramine / Q000008:administration & dosage; D014661:Vasoconstriction / Q000187:drug effects*; D055815:Young Adult
chemical_list: D001950:Bretylium Tosylate; D001205:Ascorbic Acid; D014439:Tyramine